Skip to main content
Erschienen in: Journal of Diabetes & Metabolic Disorders 2/2018

01.09.2018 | Review Article

An association between IL-10 promoter polymorphisms and diabetic nephropathy: a meta-analysis of case-control studies

verfasst von: Cho Naing, Norah Htet Htet, Arun Kumar Basavaraj, Sivalingam Nalliah

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

This study aimed to synthesize evidence on the association between IL-10 gene (−819 C/T, −1082 A/G, −592 A/C) polymorphisms and the risk of developing diabetic nephropathy.

Methods

A systematic literature search was done in health-related electronic databases. The search was limited to studies published in English until September 2017. We also checked the references of retrieved articles and relevant reviews for any additional studies. The methodological quality of the studies included in this review was assessed using the ‘Scales for Quality Assessment’. The I2 test was used to quantify between-study heterogeneity. A value of I2 > 50% indicated substantial heterogeneity. For the pooled analysis, summary odds ratio (OR) and its 95% confidence interval (CI) in random effect model were used.

Results

Eight case-control studies (1192 cases with diabetic nephropathy and 2399 controls) met the inclusion criteria. Three groups of people namely Africans, Asians and Caucasians were included in this review. There were significant protective effects of SNP -819 C/T in overall population (OR 0.32, 95% CI 0.26–0.4) and − 1082 A/G SNP in the Asian population (OR 0.64, 95% CI 0.47–0.86) on diabetic nephropathy in the recessive model. There was no significant effect of −592 A/C on diabetic nephropathy.

Conclusion

The findings suggest the protective effects of −1082A/G and -819G/A polymorphisms on the risk of developing diabetic nephropathy in type 2 diabetes mellitus, especially in the Asian population. Well- designed, prospective studies with sufficient number of participants are recommended to substantiate these findings.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Lyssenko V, Laakso M. Genetic screening for the risk of type 2 diabetes: worthless or valuable? Diabetes Care. 2013;36:120–6.CrossRef Lyssenko V, Laakso M. Genetic screening for the risk of type 2 diabetes: worthless or valuable? Diabetes Care. 2013;36:120–6.CrossRef
2.
Zurück zum Zitat Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683–765.CrossRefPubMed Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683–765.CrossRefPubMed
3.
4.
Zurück zum Zitat Bijjiga E, Martino AT. Interleukin 10 (IL-10) regulatory cytokine and its clinical consequences. J Clin Cell Immunol. 2013;S1:007. Bijjiga E, Martino AT. Interleukin 10 (IL-10) regulatory cytokine and its clinical consequences. J Clin Cell Immunol. 2013;S1:007.
5.
6.
Zurück zum Zitat Navarro-Gonzalez JF, Mora-Fernandez C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol. 2008;19:433–42.CrossRefPubMed Navarro-Gonzalez JF, Mora-Fernandez C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol. 2008;19:433–42.CrossRefPubMed
7.
Zurück zum Zitat Montazeri S, Nalliah S, Radhakrishnan AK. Is there a genetic variation association in the IL-10 and TNF alpha promoter gene with gestational diabetes mellitus? Hereditas. 2010;147:94–102.CrossRefPubMed Montazeri S, Nalliah S, Radhakrishnan AK. Is there a genetic variation association in the IL-10 and TNF alpha promoter gene with gestational diabetes mellitus? Hereditas. 2010;147:94–102.CrossRefPubMed
8.
Zurück zum Zitat Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics. 1997;46:120–8.CrossRefPubMed Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics. 1997;46:120–8.CrossRefPubMed
9.
Zurück zum Zitat Karhukorpi J, Laitinen T, Karttunen R, Tiilikainen AS. The functionally important IL-10 promoter polymorphism (−1082G→A) is not a major genetic regulator in recurrent spontaneous abortions. Mol Hum Reprod. 2001;7:201–3.CrossRefPubMed Karhukorpi J, Laitinen T, Karttunen R, Tiilikainen AS. The functionally important IL-10 promoter polymorphism (−1082G→A) is not a major genetic regulator in recurrent spontaneous abortions. Mol Hum Reprod. 2001;7:201–3.CrossRefPubMed
10.
Zurück zum Zitat Kilpinen S, Huhtala H, Hurme M. The combination of the interleukin-1α (IL-1α-889) genotype and the interleukin-10 (IL-10 ATA) haplotype is associated with increased interleukin-10 (IL-10) plasma levels in healthy individuals. Eur Cytokine Netw. 2002;13:66–71.PubMed Kilpinen S, Huhtala H, Hurme M. The combination of the interleukin-1α (IL-1α-889) genotype and the interleukin-10 (IL-10 ATA) haplotype is associated with increased interleukin-10 (IL-10) plasma levels in healthy individuals. Eur Cytokine Netw. 2002;13:66–71.PubMed
11.
Zurück zum Zitat Temple SE, Lim E, Cheong KY, Almeida CA, Price P, Ardlie KG, et al. Alleles carried at positions −819 and −592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae. Immunogenetics. 2003;55:629–32.CrossRefPubMed Temple SE, Lim E, Cheong KY, Almeida CA, Price P, Ardlie KG, et al. Alleles carried at positions −819 and −592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae. Immunogenetics. 2003;55:629–32.CrossRefPubMed
12.
Zurück zum Zitat Seaquist ER, Goetz FC, Rich SS, Barbosa J. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1998;320:1161–5.CrossRef Seaquist ER, Goetz FC, Rich SS, Barbosa J. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1998;320:1161–5.CrossRef
13.
14.
Zurück zum Zitat Yaghini N, Mahmoodi M, Asadikaram GR, Hassanshahi GH, Khoramdelazad H, Arababadi M. Serum levels of interleukin 10 (IL-10) in patients with type 2 diabetic. Iran Red Crescent Med J. 2011;13:752.PubMedPubMedCentral Yaghini N, Mahmoodi M, Asadikaram GR, Hassanshahi GH, Khoramdelazad H, Arababadi M. Serum levels of interleukin 10 (IL-10) in patients with type 2 diabetic. Iran Red Crescent Med J. 2011;13:752.PubMedPubMedCentral
15.
Zurück zum Zitat Higgins JPT, Green S, ed. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration; 2011. Available from http://handbook.cochrane.org. Accessed 18 May 2018. Higgins JPT, Green S, ed. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration; 2011. Available from http://​handbook.​cochrane.​org. Accessed 18 May 2018.
16.
Zurück zum Zitat Attia J, Thakkinstian A, D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol. 2003;56:297–303.CrossRefPubMed Attia J, Thakkinstian A, D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol. 2003;56:297–303.CrossRefPubMed
17.
Zurück zum Zitat Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, Duffy D, et al. Systematic review and meta-analysis of the association between{h}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol. 2005;162:201–11.CrossRefPubMed Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, Duffy D, et al. Systematic review and meta-analysis of the association between{h}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol. 2005;162:201–11.CrossRefPubMed
18.
Zurück zum Zitat Guo SW, Thompson EA. 1992. Performing the exact test of hardy-Weinberg proportion for multiple alleles. Biometrics. 1992;48:361–72.CrossRefPubMed Guo SW, Thompson EA. 1992. Performing the exact test of hardy-Weinberg proportion for multiple alleles. Biometrics. 1992;48:361–72.CrossRefPubMed
20.
Zurück zum Zitat Zintzaras E, Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol. 2008;61:634–45.CrossRefPubMed Zintzaras E, Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol. 2008;61:634–45.CrossRefPubMed
22.
Zurück zum Zitat Babel N, Gabdrakhmanova L, Hammer MH, Schoenemann C, Skrypnikov V, Poliak N, et al. Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease. J Nephrol. 2006;19:802–7.PubMed Babel N, Gabdrakhmanova L, Hammer MH, Schoenemann C, Skrypnikov V, Poliak N, et al. Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease. J Nephrol. 2006;19:802–7.PubMed
23.
Zurück zum Zitat Ezzidi I, Mtiraoui N, Kacem M, Mallat SG, Mohamed MBH, Chaieb M, et al. Interleukin-10-592 C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients. Clin Endocrinol. 2009;70:401–7.CrossRef Ezzidi I, Mtiraoui N, Kacem M, Mallat SG, Mohamed MBH, Chaieb M, et al. Interleukin-10-592 C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients. Clin Endocrinol. 2009;70:401–7.CrossRef
24.
Zurück zum Zitat Kung WJ, Lin CC, Liu SH, Chaung HC. Association of interleukin-10 polymorphisms with cytokines in type 2 diabetes nephropathy. Diabetes Technol Ther. 2010;12:809–13.CrossRefPubMed Kung WJ, Lin CC, Liu SH, Chaung HC. Association of interleukin-10 polymorphisms with cytokines in type 2 diabetes nephropathy. Diabetes Technol Ther. 2010;12:809–13.CrossRefPubMed
25.
Zurück zum Zitat Erdogan M, Cetinkalp S, Ozgen AG, Saygili F, Berdeli A, Yilmaz C. Interleukin-10 (−1082G/a) gene polymorphism in patients with type 2 diabetes with and without nephropathy. Genet Test Mol Biomarkers. 2012;16:91–4.CrossRefPubMed Erdogan M, Cetinkalp S, Ozgen AG, Saygili F, Berdeli A, Yilmaz C. Interleukin-10 (−1082G/a) gene polymorphism in patients with type 2 diabetes with and without nephropathy. Genet Test Mol Biomarkers. 2012;16:91–4.CrossRefPubMed
26.
Zurück zum Zitat Arababadi MK, Reza Mirzaei M, et al. Interleukin (IL)-10 gene polymorphisms are associated with type 2 diabetes with and without nephropathy: a study of patients from the southeast region of Iran. Inflammation. 2012;35:797–802.CrossRefPubMed Arababadi MK, Reza Mirzaei M, et al. Interleukin (IL)-10 gene polymorphisms are associated with type 2 diabetes with and without nephropathy: a study of patients from the southeast region of Iran. Inflammation. 2012;35:797–802.CrossRefPubMed
27.
Zurück zum Zitat Yin Q, Zhai Q, Wang D, Hai J, Cao M, Wang J, et al. Investigation on the association between inerleukin-10-592C/A, 819C/T and -1082A/G gene polymorphisms and development of diabetic nephropathy. Int J Clin Exp Pathol. 2015;8:15216–21.PubMedPubMedCentral Yin Q, Zhai Q, Wang D, Hai J, Cao M, Wang J, et al. Investigation on the association between inerleukin-10-592C/A, 819C/T and -1082A/G gene polymorphisms and development of diabetic nephropathy. Int J Clin Exp Pathol. 2015;8:15216–21.PubMedPubMedCentral
29.
Zurück zum Zitat Mahmoud AA, Sheneef A, Sayed AA, Ezat MAW, Sabet EA. Association of interleukin-10 (−592 A/C) gene polymorphism with its level in type 2 diabetes mellitus with and without nephropathy. Mol Genet Med. 2016;10:1. Mahmoud AA, Sheneef A, Sayed AA, Ezat MAW, Sabet EA. Association of interleukin-10 (−592 A/C) gene polymorphism with its level in type 2 diabetes mellitus with and without nephropathy. Mol Genet Med. 2016;10:1.
30.
Zurück zum Zitat Wu HC, Ling H, Na SP, Xie RJ. The research on the relationship between the polymorphism of 1082A/G, anti-inflammatory interleukin-10 gene promoter with its effect of preventing ESRD patients from microinflammation and arteriosclerosis. Zhonghua Yi Xue Za Zhi. 2005;85:2076–80.PubMed Wu HC, Ling H, Na SP, Xie RJ. The research on the relationship between the polymorphism of 1082A/G, anti-inflammatory interleukin-10 gene promoter with its effect of preventing ESRD patients from microinflammation and arteriosclerosis. Zhonghua Yi Xue Za Zhi. 2005;85:2076–80.PubMed
31.
Zurück zum Zitat Rodrigues KF, Pietrani NT, Sandrim VC, Vieira MAF, Fernandes AP, Bosco AA, et al. Association of a large panel of cytokine gene polymorphisms with complications and comorbidities in type 2 diabetes patients. J Diabeties Res. 2015; https://doi.org/10.1155/2015/605965. Rodrigues KF, Pietrani NT, Sandrim VC, Vieira MAF, Fernandes AP, Bosco AA, et al. Association of a large panel of cytokine gene polymorphisms with complications and comorbidities in type 2 diabetes patients. J Diabeties Res. 2015; https://​doi.​org/​10.​1155/​2015/​605965.
32.
Zurück zum Zitat Tsiavou A, Hatziagelaki E, Chaidaroglou A, Manginas A, Koniavitou K, Degiannis D, et al. TNF-alpha, TGF-beta1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetic of adults (LADA) and type 2 diabetes mellitus. J Clin Immunol. 2004;24:591–9.CrossRefPubMed Tsiavou A, Hatziagelaki E, Chaidaroglou A, Manginas A, Koniavitou K, Degiannis D, et al. TNF-alpha, TGF-beta1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetic of adults (LADA) and type 2 diabetes mellitus. J Clin Immunol. 2004;24:591–9.CrossRefPubMed
33.
Zurück zum Zitat Chang YH, Huang CN, Wu CY, Shiau MY. Association of interleukin-10 −592 C/A and −819C/T polymorphisms with type 2 diabetes mellitus. Hum Immunol. 2005;66:1258–63.CrossRefPubMed Chang YH, Huang CN, Wu CY, Shiau MY. Association of interleukin-10 −592 C/A and −819C/T polymorphisms with type 2 diabetes mellitus. Hum Immunol. 2005;66:1258–63.CrossRefPubMed
34.
Zurück zum Zitat Scarpelli D, Cardellini M, Andreozzi F, Laratta E, Hribal ML, Marini MA, et al. Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in Caucasian Italian subjects. Diabetes. 2006;55:1529–33.CrossRefPubMed Scarpelli D, Cardellini M, Andreozzi F, Laratta E, Hribal ML, Marini MA, et al. Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in Caucasian Italian subjects. Diabetes. 2006;55:1529–33.CrossRefPubMed
35.
Zurück zum Zitat Saxena M, Agrawal CC, Bid HK, Banerjee M. An interleukin-10 gene promoter polymorphism (−592A/C) associated with type 2 diabetes: a north Indian study. Biochem Genet. 2012;50:549–59.CrossRefPubMed Saxena M, Agrawal CC, Bid HK, Banerjee M. An interleukin-10 gene promoter polymorphism (−592A/C) associated with type 2 diabetes: a north Indian study. Biochem Genet. 2012;50:549–59.CrossRefPubMed
36.
Zurück zum Zitat Mtiraoui N, Ezzidi I, Kacem M, Ben Hadj Mohamed M, Chaieb M, Haj Jilani AB, et al. Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetic patients. Diabetes Metab Res Rev. 2009;25:57–63.CrossRefPubMed Mtiraoui N, Ezzidi I, Kacem M, Ben Hadj Mohamed M, Chaieb M, Haj Jilani AB, et al. Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetic patients. Diabetes Metab Res Rev. 2009;25:57–63.CrossRefPubMed
37.
Zurück zum Zitat World Health Organization (WHO). WHO expert committee on diabetes mellitus. WHO technical report series No. 646. Geneva: WHO; 1980. World Health Organization (WHO). WHO expert committee on diabetes mellitus. WHO technical report series No. 646. Geneva: WHO; 1980.
38.
Zurück zum Zitat American Diabeties Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27:S5–S10.CrossRef American Diabeties Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27:S5–S10.CrossRef
39.
Zurück zum Zitat Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol. 2008;180:5771–7.CrossRefPubMed Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol. 2008;180:5771–7.CrossRefPubMed
40.
Zurück zum Zitat Zhang F, Yang Y, Lei H, Qiu J, Wang Y, Hu D, et al. A meta-analysis about the association between −1082 G/A and -819 C/T polymorphisms of IL-10 gene and risk of type 2 diabetes. Hum Immunol. 2013;74:618–26.CrossRefPubMed Zhang F, Yang Y, Lei H, Qiu J, Wang Y, Hu D, et al. A meta-analysis about the association between −1082 G/A and -819 C/T polymorphisms of IL-10 gene and risk of type 2 diabetes. Hum Immunol. 2013;74:618–26.CrossRefPubMed
41.
Zurück zum Zitat Mysliwska J, Zorena K, Semetkowska-Jurkiewicz E, Rachon D, Suchanek H, Mysliwski A. High levels of circulating interleukin-10 in diabetic nephropathy patients. Eur Cytokine Netw. 2005;16:117–22.PubMed Mysliwska J, Zorena K, Semetkowska-Jurkiewicz E, Rachon D, Suchanek H, Mysliwski A. High levels of circulating interleukin-10 in diabetic nephropathy patients. Eur Cytokine Netw. 2005;16:117–22.PubMed
42.
Zurück zum Zitat Saraheimo M, Teppo AM, Forsblom C, Fagerudd J, Groop PH. Diabetic nephropathy is associated with low-grade inflammation in type diabetic patients. Diabetologia. 2003;46:1402–7.CrossRefPubMed Saraheimo M, Teppo AM, Forsblom C, Fagerudd J, Groop PH. Diabetic nephropathy is associated with low-grade inflammation in type diabetic patients. Diabetologia. 2003;46:1402–7.CrossRefPubMed
Metadaten
Titel
An association between IL-10 promoter polymorphisms and diabetic nephropathy: a meta-analysis of case-control studies
verfasst von
Cho Naing
Norah Htet Htet
Arun Kumar Basavaraj
Sivalingam Nalliah
Publikationsdatum
01.09.2018
Verlag
Springer International Publishing
Erschienen in
Journal of Diabetes & Metabolic Disorders / Ausgabe 2/2018
Elektronische ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-018-0349-3

Weitere Artikel der Ausgabe 2/2018

Journal of Diabetes & Metabolic Disorders 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.